PITUITARY ADENOMAS EVALUATION USING MAGNETIC RESONANCE IMAGING: A SINGLE-CENTER OBSERVATIONAL STUDY
Main Article Content
Keywords
Pituitary adenoma, microadenoma, macroadenoma, MRI, Dynamic MR
Abstract
Objective: To assess magnetic resonance imaging's (MRI) precision and efficacy in the early identification of pituitary adenomas.
Methodology: In this cross-sectional study conducted at Chandka Medical College Hospital, Shaheed Muhtarma Benazeer Bhutto Medical University, Larkana, Sindh, Pakistan, 70 patients suspected of pituitary lesions were examined using MRI. All subjects gave their informed consent, and ethical approval was secured. Patients underwent thorough clinical evaluations and laboratory tests to assess pituitary function and rule out contraindications for MRI. MRI scans were performed using a 1.5 Tesla unit, with a standardized protocol including pre-contrast and post-contrast T1 and T2-weighted images. Dynamic imaging was conducted following gadolinium contrast administration. The study aimed to correlate clinical findings with MRI results to enhance diagnostic accuracy and guide patient management.
Results: In a cohort of 70 suspected patients of pituitary lesions, comprising 38 males and 32 females, our study identified 43 cases (61.4%) of pituitary macroadenoma and 27 cases (38.6%) of microadenoma. Clinical presentations included headaches (30%), visual disturbances (25%), or a combination of both (33%), with a minority exhibiting acromegaly (1%) or various hormonal irregularities. MRI revealed diverse characteristics of macroadenomas, extending in size from 1.2 to 4.9cm, with predominant homogeneous signal-intensity (60.5%) and encasement of the infundibulum (83.7%). Additionally, microadenomas typically exhibited isointense signals on T1WI (81.5%) and ranged in size from 3 to 9 mm, with lateral localization in the majority (85.2%). Elevated prolactin levels were common in both macroadenomas (90.7%) and microadenomas (81.5%).
Conclusion: This particular research highlights the critical importance of MRI in diagnosing and treating conditions related to the hypothalamus and pituitary gland. Through its ability to provide detailed imaging and differentiate between various disorders, MRI plays a crucial role in guiding treatment decisions, whether surgical or conservative. Our study emphasizes the essential role of MRI in optimizing patient care and tracking treatment progress, demonstrating its significance in improving overall patient outcomes.
References
2. Reeves RA, Parekh M. Pituitary Gland Imaging. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555989/
3. Tsukamoto T, Miki Y. Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma. Jpn J Radiol. 2023;41:789–806. Available from: https://doi.org/10.1007/s11604-023-01400-7
4. Petersenn S, Fleseriu M, Casanueva FF, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023;19:722–740. Available from: https://doi.org/10.1038/s41574-023-00886-5
5. Chaudhary V, Bano S. Imaging of the pituitary: Recent advances. Indian J Endocrinol Metab. 2011;15 Suppl 3:S216–S223. Available from: https://doi.org/10.4103/2230-8210.84871
6. Guo R, Wu Y, Guo G, Zhou H, Liu S, Yao Z, Xiao Y. Application of Contrast-Enhanced 3-Dimensional T2-Weighted Volume Isotropic Turbo Spin Echo Acquisition Sequence in the Diagnosis of Prolactin-Secreting Pituitary Microadenomas. J Comput Assist Tomogr. 2022;46:116–123. Available from: https://doi.org/10.1097/RCT.0000000000001237
7. Yao A, Balchandani P, Shrivastava RK. Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities. World Neurosurg. 2017;104:489–498. Available from: https://doi.org/10.1016/j.wneu.2017.04.128
8. O'Connor JP, Tofts PS, Miles KA, Parkes LM, Thompson G, Jackson A. Dynamic contrast-enhanced imaging techniques: CT and MRI. Br J Radiol. 2011;84 Spec No 2:S112–S120. Available from: https://doi.org/10.1259/bjr/55166688
9. Banskota S, Adamson DC. Pituitary Adenomas: From Diagnosis to Therapeutics. Biomedicines. 2021;9:494. Available from: https://doi.org/10.3390/biomedicines9050494
10. Sen R, Sen C, Pack J, Block KT, Golfinos JG, Prabhu V, Boada F, Gonen O, Kondziolka D, Fatterpekar G. Role of High-Resolution Dynamic Contrast-Enhanced MRI with Golden-Angle Radial Sparse Parallel Reconstruction to Identify the Normal Pituitary Gland in Patients with Macroadenomas. AJNR Am J Neuroradiol. 2017;38:1117–1121. Available from: https://doi.org/10.3174/ajnr.A5244
11. Ugga L, Franca RA, Scaravilli A, Solari D, Cocozza S, Tortora F, Cavallo LM, De Caro MDB, Elefante A. Neoplasms and tumor-like lesions of the sellar region: imaging findings with correlation to pathology and 2021 WHO classification. Neuroradiology. 2023;65:675–699. Available from: https://doi.org/10.1007/s00234-023-03120-1
12. Varrassi M, Cobianchi Bellisari F, Bruno F, Palumbo P, Natella R, Maggialetti N, De Filippo M, Di Cesare E, Barile A, Masciocchi C, Caranci F, Splendiani A. High-resolution magnetic resonance imaging at 3T of pituitary gland: advantages and pitfalls. Gland Surg. 2019;8 Suppl 3:S208–S215. Available from: https://doi.org/10.21037/gs.2019.06.08
13. Jane JA Jr, Catalino MP, Laws ER Jr. Surgical Treatment of Pituitary Adenomas. [Updated 2022 Mar 9]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278983/
14. Bakker LEH, Verstegen MJT, Ghariq E, et al. Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery. Pituitary. 2022;25:587–601. Available from: https://doi.org/10.1007/s11102-022-01230-2
15. Sakamoto Y, Takahashi M, Korogi Y, Bussaka H, Ushio Y. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging. Radiology. 1991;178:441–445.
16. Miki Y, Matsuo M, Nishizawa S, et al. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology. 1990;177:35–38.
17. Thomas T, Gopalakrishnan CV, Thomas B, Nair SM. Evaluation of Consistency of Pituitary Macroadenoma Using Diffusion-weighted Imaging in Correlation With Surgical Findings. Neurosurg Q. 2014;24:131–135. Available from: https://doi.org/10.1097/WNQ.0b013e31828cc38d
18. Stadnik T, Stevenaert A, Beckers A, Luypaert R, Buisseret T, Osteaux M. Pituitary microadenomas: diagnosis with two- and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium. Radiology. 1990;176:419–428.
19. Connor SE, Wilson F, Hogarth K. Magnetic resonance imaging criteria to predict complete excision of parasellar pituitary macroadenoma on postoperative imaging. J Neurol Surg B. 2014;75:41–46.
20. Bartynski WS, Lin L. Dynamic and conventional spin-echo MR of pituitary microlesions. AJNR Am J Neuroradiol. 1997;18:965–972.